Study To Assess The Clinical Benefit Of Droxidopa In Subjects With Chronic Fatigue Syndrome

NCT00977171 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

INDUSTRY

Sponsor class

Stopped Enrollment issues.

Conditions

Chronic Fatigue Syndrome
Orthostatic Hypotension
Neurally Mediated Hypotension
Neurogenic Orthostatic Hypotension

Interventions

DRUG: Droxidopa

Sponsor

Chelsea Therapeutics